NCT06435806 Medical Illustration Design Characteristic Evaluation
| NCT ID | NCT06435806 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northeastern University |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 8,200 participants |
| Start Date | 2024-03-25 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 8,200 participants in total. It began in 2024-03-25 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to understand what people understand from medical illustrations, and what meaning and emotions (such as anxiety) they derive from different design elements.
Eligibility Criteria
Inclusion Criteria: * Over 18 years old * Speaks English or Spanish fluently * Is able to independently consent * Has adequate corrected vision to read patient education documents Exclusion Criteria: \* None
Contact & Investigator
Timothy Bickmore, PhD
PRINCIPAL INVESTIGATOR
Northeastern University
Frequently Asked Questions
Who can join the NCT06435806 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06435806 currently recruiting?
Yes, NCT06435806 is actively recruiting participants. Contact the research team at t.bickmore@northeastern.edu for enrollment information.
Where is the NCT06435806 trial being conducted?
This trial is being conducted at Boston, United States, Boston, United States.
Who is sponsoring the NCT06435806 clinical trial?
NCT06435806 is sponsored by Northeastern University. The principal investigator is Timothy Bickmore, PhD at Northeastern University. The trial plans to enroll 8,200 participants.